NCT04672434 2024-12-09Sym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor MalignanciesSymphogen A/SPhase 1 Completed48 enrolled
NCT02466568 2019-09-09Study of Nivolumab in Combination With GM.CD40L Vaccine in Adenocarcinoma of the LungH. Lee Moffitt Cancer Center and Research InstitutePhase 1/2 Withdrawn